Cholesterol Drug Alirocumab Shields the Heart From Alcohol Damage in Rat Study
A new GeroScience study shows that weekly alirocumab, an approved PCSK9 inhibitor, protected rats from alcohol-induced cardiac dysfunction, fibrosis, and ...
A new GeroScience study shows that weekly alirocumab, an approved PCSK9 inhibitor, protected rats from alcohol-induced cardiac dysfunction, fibrosis, and ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.